BDBM25025 4-[2-(1H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine::thieno[3,2-d]pyrimidine derivative, 20
SMILES: C1CN(CCO1)c1nc(nc2ccsc12)-c1cccc2[nH]ncc12
InChI Key: InChIKey=GXJBABITGPOFCK-UHFFFAOYSA-N
Data: 2 IC50
PDB links: 1 PDB ID contains this monomer as substructures. 1 PDB ID contains inhibitors having a similarity of 90% to this monomer.
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Homo sapiens (Human)) | BDBM25025 (4-[2-(1H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Curated by ChEMBL | Assay Description Inhibition of PI3Kalpha assessed as reduction in PIP3 formation after 30 mins by fluorescence polarization assay | J Med Chem 55: 8007-20 (2012) Article DOI: 10.1021/jm300867c BindingDB Entry DOI: 10.7270/Q2MC9152 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
p110α/p85α (Homo sapiens (Human)) | BDBM25025 (4-[2-(1H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl]...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 102 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma | Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... | J Med Chem 51: 5522-32 (2008) Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 | |||||||||||
More data for this Ligand-Target Pair |